GAD1 and type 1 diabetes mellitus: Although we found no significant difference between T1D frequencies before and during COVID-19 pandemic, autoantibodies such as Anti-GAD and Anti-IA2 titers interestingly increased during the pandemic period compared with the pre-pandemic period (p=0.021), (p=0.009) respectively.